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4,4'-Methylene-bis(2-chloroaniline) (MOCA) iswidely usedasacuringagentintheplasticsindustry. Thedetermina-
tionofthecovalently boundreactionproductstohemoglobin(Jib) hasbeeninvestigated asabiomonitoring methodfor
occupational exposuretothispotential humancardnogen. Initial studiesusingthe C-ring-labeledMOCAshowedthat
24hrafterasingle IPdosagetorats (3.74,mole/kg), 0.0% oftheadministered dose wasadducted totheHb, and base
hydrolysis liberated38%oftheboundradioactivity. Theonlyproduct releasedonhydrolysis wastheparentdiamine. A
specific and sensitiveassay procedure usingcapillary gaschromatography-mass spectrometry has been developed for
determiningthebase-releasedMOCAadductdowntolevelsof20pmole/gJHb. Thismethodhasbeenusedtoestablisha
linear dose-response relationship in IP dosed rats between production ofthe adduct and dose ofMOCA (3.74-44.94
Mmole/kg). It isproposed to useanalysis ofthe Hbadduct asadosimeter forindustrial workersexposed toMOCA.
Introduction
4,4'-Methylene-bis(2-chloroaniline) (MOCA) is a commer-
cially important aromatic amine used in the production ofiso-
cyanates, polyurethane foams, and epoxy resins. Ofimportance
with regard to the widespread industrial exposure, which can
readily occur through skin absorption, is its reported car-
cinogenicity in mice, rats, and dogs (1,2). Measurement of
MOCA levels inurine (3,4) maybeusedforbiological monitor-
ing, but this only indicates recent exposure, andthe results de-
pend critically onthetimeofsampling. The useofhemoglobin
(Hb) adducts asdosimeters foraromatic amines aswell asother
genotoxic agents allows aretrospective assessmentofexposure
andgives anindicationoftheextentofmetabolicactivation(5-7).
The mechanism ofadduct formation between aromatic amines
and Hb is believed to involvethereactionofN-oxidized metabo-
lites ofthe amine with cysteine residues to form a sulfinic acid
amide. Evidence for suchreactions in vitro hasbeenobtained for
MOCA by Chen et al. (8). Sulfinic acid amide adducts can be
readily liberated fromHbbymildhydrolysis, yieldingtheparent
amine, the determination ofwhich has been used fbrassessing
human exposure to 4-aminobiphenyl (9), aniline and p-
chloroaniline (10), and 4,4'-methylenedianiline (MDA) (11).
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Measurements ofMOCAadducts inratHb havebeen made by
radiochemical (12), high-performance liquid chromatography
(HPLC) with electrochemical detection (13), gas chromatog-
raphy-mass spectrometry (GC-MS) (13), andbyGC withelec-
tron capture detection (8). We report here on an improved
GC-MS method, using a stable isotope-labeled internal stan-
dard, forthedeterminationofMOCAHbadductsandreporton
its application to binding studies inthe rat.
Materials and Methods
Ring 14C-labeled MOCA (specific activity 56 mCi/mmole)
wasobtainedfromAmersham International (Amersham, UK).
Unlabeled MOCA was recrystallized from aqueous methanol.
The purity ofboth compounds was > 98%. Pentafluoropro-
pionic anhydride (PFPA) (Pierce, Rockford, IL) was used
withoutfurtherpurification. AllsolventswereofAnalargrade
and were redistilled before use. The synthesis of2H6-MOCA
usedastheinternal standardwillbedescribedinaforthcoming
publication.
Animal Studies
Female LAC Porton-derived Wistar rats (body weight
170-200g, 8-10weeksold)wereadministeredeither14C-MOCA
orunlabeledMOCAIPindimethylsulfoxide. Thelabeledcom-
poundwasgivenatadoselevelof3.74pmole/kgandtheunlabeled
MOCA atdosesof3.74, 11.23, 26.21, and44.94tsmole/kg (two
animalsperdose). Twenty-fourhoursafterdosing, blood sam-176 BAILEYETAL.
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FIGURE 1. Selective ion recording (m/z 523, 529) from theanalysis ofbase-
released 4,4'-methylene-bis(2-chloroaniline) (MOCA) in thehemoglobin
from a rat given a single IP dose of3.74 .tmole/kg MOCA.
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FIGURE 2. Dose-response relationship for the formation of adducted
4,4'-methylene-bis(2-chloroaniline) (MOCA) in hemoglobin after IP ex-
posure ofrats to MOCA (3.74-44.94jAmole/kg).
ples were collected into heparinized syringes viathedescending
aortawhileanimalswereunderetheranesthesia. Hbwasisolated
from the blood as described previously (11).
Determination ofHemoglobin Adducts
The analytical method for determining MOCA released by
hydrolysis fromHbisbasedontheGC-MSproceduredeveloped
previously forquantifyingadductsofMDAtoHb (11). Briefly,
itinvolves thefollowing steps: a)hydrolysisoftheHbsample (20
mg) in 1 NNaOH (4mL)for2hrinthepresenceoftheinternal
standard2H6-MOCA(5ng);b)extractionofthehydrolysatethree
times withethylacetate (2.5 mL); c)evaporationofthecombined
solvent extracts and derivatization with PFPA (3 uL) in ethyl
acetate (0.5 mL) for30minatroomtemperature;d) analysisof
thederivatized extractbycapillary GC(25 m x 0.32mmSE52)
with selective ion recording (SIR) MS.
SIRwas madeintheelectron impactmode(El)monitoringthe
fragment ions at m/z 523 (M-Cl)+ derived from the N,N'-di-
substituted PFPA derivative of MOCA together with the cor-
responding fragment ions at m/z 529 from the 2H6-MOCA
usedastheinternalstandard. Quantitationwasmadebyreference
tocalibration curves constructed fromtheanalysisof20 mg of
control rat Hb spiked with 2H6-MOCA (5 ng) andfrom 0 to 30
ngunlabeled MOCA. Peakheight ratios m/z523:mlz 529 were
linearly relatedtotheamountofMOCAadded (e.g., r = 0.9995;
y = 0.1295; x = -0.0397).
Results and Discussion
Twenty-four hours after a single IP dosage ofrats with 14C-
MOCA (3.74jtmole/kg), 0.08% ofthe administered dose was
covalentlyboundtotheHb. Basehydrolysis liberated38% ofthe
adductedradioactivity. Theonly releasedproductobserved on
thin-layer chromatography with radioscanning was the parent
diamine, whichwasidentifiedbyGC-MSafterPFPAderivatiza-
tion. Ethyl acetate extraction ofMOCA from Hbhydrolysates
gave recoveries of87.06% ± 2.12% (mean ± SD, n = 6). The
reactionofMOCAwithPFPAwasquantitativeandtheN,N'-di-
PFPAderivativehadexcellentGCproperties. Monitoring the in-
tense fragmention intheEImass spectrum atm/z523 (M+-Cl)
allowed 10pgofthederivatizedcompoundtobedetectedby SIR.
Atypical SIRtracefromtheanalysisofthe MOCAderived ad-
duct in the Hb of a rat administered a single IP dose of 3.74
,umole/kg MOCA is illustrated inFigure 1. Theaccuracy ofthe
method was assured by the use of a deuterated analogue of
MOCAasaninternal standard. Themeancalculated recoveries
ofauthenticMOCA spiked into control rat Hb atlevels of7 ng
and 25 ng/20 mg Hb were 98.48% (SD ± 1.33%, n = 6) and
100.34% (SD ± 3.49%, n = 6), respectively.
Thelevelofbase-released MOCAadductinratHbincreased
linearly withdoseoverthe range 3.74-44.94 ,umole/kg MOCA
(Fig. 2). The determined hemoglobin binding index (binding
mmole/moleHb:dosemmole/kg) oftheadductof2.63 + 0.204
(mean ± SEM) wasconstantoverthisdoserange. Inconclusion,
thedescribedmethod shouldbeuseful asadosemonitorforin-
dustrial workers exposedto MOCA. The detection limitofthe
method, which is 20pmoleadduct/g Hbmay, however, have to
be lowered to allow monitoring oflow levels ofexposure. This
canbereadilyachievedbyoperating theMS inthenegative ion
chemical ionization mode, giving a 10-fold improvement in
detection limit.
This manuscriptwaspresented asaposterattheConferenceon Biomonitor-
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